Skip to main content
. 2012 May 11;7(5):e36792. doi: 10.1371/journal.pone.0036792

Table 3. Factors associated with non-enrolment, high WHO stage and CD4 count <350 cells/mm3 among adult HIV patients diagnosed in eight Rwanda health facilities, 2009: logistic regression.

Non enrolment WHO stage 3 or 4 CD4 count <350 cells/mm3
n/N OR (95%CI) n/N OR (95%CI) n/N OR (95%CI)
274/472 28/176 79/185
Study sites
Muhoza 113/150 1 6/37 1 17/37 1
Ruhengeri 0/6 N.A. 4/6 10.3 (1.5–69.7) 4/6 2.4 (0.4–14.5)
Gasiza 11/17 0.6 (0.2–1.7) 3/6 5.2 (0.8–32.0) 4/6 2.4 (0.4–14.5)
Kibagabaga 46/84 0.4 (0.2–0.7) 1/28 0.2 (0.02–1.7) 13/34 0.7 (0.3–1.9)
Kinyinya 28/48 0.5 (0.2–0.9) 2/18 0.6 (0.1–3.6) 6/14 0.9 (0.3–3.1)
Kimironko 36/98 0.2 (0.1–0.3) 8/56 0.9 (0.3–.2.7) 25/60 0.8 (0.4–1.9)
Rwaza 12/23 0.4 (0.1–0.9) 3/11 1.9 (0.4–9.5) 5/11 1.0 (0.3–3.8)
Kabuye 28/46 0.5 (0.3–1.0) 1/14 0.4 (0.04–3.6) 5/17 0.5 (0.1–1.7)
p-value <0.0001 0.011 0.712
Departments
VCT 174/285 1 15/101 1 40/104 1
ANC 53/99 0.7 (0.5–1.2) 1/38 0.15 (0.02–1.2) 14/43 0.8 (0.4–1.6)
TB 3/10 0.3 (0.1–1.1) 4/7 7.6 (1.6–37.6) 6/7 9.6 (1.1–82.7)
OPD 44/78 0.8 (0.5–1.4) 8/30 2.1 (0.8–5.5) 19/31 2.5 (1.1–5.8)
p-value 0.159 0.0013 0.0058
Age
15–24 years 70/121 1.7 (0.9–3.2) 4/44 0.1 (0.04–0.5) 12/46 0.2 (0.07–0.5)
25–34 years 113/192 1.7 (0.9–3.2) 8/69 0.2 (0.1–0.5) 31/76 0.4 (0.2–0.9)
35–44 years 58/97 1.8 (0.9–3.5) 4/35 0.2 (0.05–0.6) 18/35 0.6 (0.2–1.6)
>45 years 24/53 1 12/28 1 18/28 1
p-value 0.316 0.002 0.0076
Sex
Female 195/333 1 16/120 1 48/128 1
Male 79/139 0.9 (0.6–1.4) 12/56 1.8 (0.8–4.1) 31/57 2.0 (1.1–3.7)
p-value 0.730 0.180 0.0335

Those aged <15 years were excluded from these analyses. NA = Not Applicable; TB Tuberculosis; ANC Antenatal care; HIV Human immunodefiency virus; OPD Outpatient department; VCT Voluntary counselling and testing; WHO World Health Organization.